USPTO 2015–2025 USPTO PatentsView US Corporation

Loyola University Of Chicago

USPTO PatentsView assignee record - 27 granted patents across 22 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

27
Total patents granted
22
CPC technology areas
13.5
Avg claims per patent
+100%
5-year grant velocity

The verdict

According to USPTO PatentsView, Loyola ranks #11,333 of 50,000 tracked US assignees by granted-patent volume, with 27 patents across 22 technology areas.

#11,333
of 50,000 US assignees by volume
Top 37%
by Innovation Score (40.0/100)
13.5
avg claims per patent
+100%
grant velocity, last 5 yrs

Portfolio overview

Loyola University Of Chicago has been granted 27 US utility patents between 2015 and 2024, placing Loyola University Of Chicago at #11,333 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 22 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.5 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a US Corporation, Loyola University Of Chicago is one of the more focused assignees in the PatentsView dataset. By volume, Loyola sits between Leopold Kostal Gmbh & Co. KG (27 patents, rank #11,329) and Mavig Gmbh (27 patents, rank #11,337) - the closest US assignees by grant volume. The composite Innovation Score of 40.0/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 18 grants, compared with 9 in the 2015–2019 window, a +100% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Loyola University Of Chicago's 13.5 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 22 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Who files at Loyola's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Loyola holds 27 patents at rank #11,333, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Loyola

By rank, the assignees closest to #11,333 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Loyola's primary technology class.

Loyola's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 201520162018201920202021202220232024 3
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Loyola University Of Chicago patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 3.7%
2016 1 3.7%
2018 3 11.1%
2019 4 14.8%
2020 6 22.2%
2021 4 14.8%
2022 1 3.7%
2023 4 14.8%
2024 3 11.1%

Which technologies does Loyola University Of Chicago patent most?

Top 15 of 22 technology areas

Grant record at a glance

Portfolio Volume 27 grants
CPC subclasses 22
Avg. claims / grant 13.5
Velocity +100%

Historical grant data only; it does not rate legal strength or current strategy.

Where it ranks

Overall rank by patents

#11,333

of 50,000 tracked assignees

Innovation Score

40.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

Where does Loyola University Of Chicago rank among US patent assignees?
According to USPTO PatentsView (2015–2025 granted utility patents), Loyola University Of Chicago ranks #11,333 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.
How many patents does Loyola University Of Chicago hold?
Loyola University Of Chicago holds 27 US utility patents granted between 2015 and 2024, spanning 22 technology areas.
What is Loyola University Of Chicago's Innovation Score?
Loyola University Of Chicago has an Innovation Score of 40.0 out of 100 (top 37% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Loyola University Of Chicago focus on?
Loyola University Of Chicago's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 13 patents. Grants appear in 22 CPC subclasses total.
Is Loyola University Of Chicago's patent grant rate increasing or decreasing?
Loyola University Of Chicago's recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.
What does claim depth mean for Loyola University Of Chicago's patents?
Loyola University Of Chicago's patents average 13.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.
How is the Loyola University Of Chicago patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Loyola's 27 grants land it in the top 37% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Loyola ranks #11,333 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61P - see who else leads that technology area. A61P leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.